Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Applications in Pharmaceutical Analysis and Forced Degradation Studies (Hall 2)

Applications in Pharmaceutical Analysis and Forced Degradation Studies (Hall 2) Agenda




Friday, 20 November 2015


Session 1: MS Tools to Study Forced Degradation

10:00

Saranjit SinghKeynote Presentation

Relevance of Forced Degradation Studies and Protocol for Characterization of Degradation Products Using Mass Tools
Saranjit Singh, Professor/Head, NIPER Mohali, India

The presentation will focus on relevance of forced degradation studies and on protocols for the characterization of forced degradation products at the level of ~0.1% using mass spectrometry tools. The same will be duly explained through multiple case studies from lab or the literature.

11:00

Application of Mass Spectrometry in Biopharmaceutical analysis and Forced Degradation Studies
Pradeep Kabadi, Principal Scientist, Biocon Research Limited, India

This presentation will highlight Extensive Characterization to establish bio-pharmaceutical proteins along with Enrichment and Characterization of product related substance. Further, it will discuss how Mass Spectrometry is used as a tool to study Forced degradation of proteins. Finally, Application of Mass Spectrometry for establishing Higher Order Structure in proteins will be covered.

11:35

Coffee Break & Networking in Exhibition Area


Session 2: Forced Degradation Studies-Method Development & Metabolite Identification

12:05

Markus ZimmerKeynote Presentation

Practically Implementing Forced Degradation Studies for Drug Product Development
Markus Zimmer, Head, SANOFI, France

13:05

Forced Degradation Studies of a General Purview
Sumathi Rao, Vice President- Formulation Analytical Research Department, Aurobindo Pharma Research center, India

13:40

Poster Viewing Session

14:00

Lunch Break


Session 3: Pharmaceutical and Biopharmaceutical Analysis using MS

15:00

Use of Mass Spectrometry for Rapid Detection of Carbapenem Resistant Gram Negative Hospital Acquired Infections
Mandar Kulkarni, Chief Technology Officer, Bioserve Biotechnologies, India

This talk will discuss the use of mass spectrometry to detect carbapenemase activity, by selectively monitoring for the appearance of carbapenem hydrolysis products in critical patient specimens: positive blood cultures and urine sample.

15:35

Role of Mass Spectrometry in enabling Quality by Design for Biopharmaceutical Analysis
Himanshu Gadgil, CSO, Enzene Biosciences, India

16:10

A High Throughput Work on Proteins Enabled through Optimization of Mass Spectrometry Parameters coupled with Liquid Chromatography
Pradeep Kabadi, Principal Scientist, Biocon Research Limited, India

This talk will cover Sample Preparations for the MS (Native and Denatured MS, Glycosylation Analysis), Tandem MS level (Peptide Mass Fingerprinting) data generation and Optimization of front end parameters of HPLC and MS- for Ionization.

16:45

Analysis of Oxidation Products in Isolated and Cellular DNA by LC-ESI-MS/MS
Guru S Madugundu, Research Scholar, University of Sherbrooke, Canada

This talk will focus on the development of several methods for quantification of Oxidant induced lesions in isolated and cellular DNA . It will further discuss about methods to measure DNA damage based on liquid chromatography coupled to electrospray tandem mass spectrometry.

17:10

End of Conference